Resources
Pharma marketing has a relevance problem, not a delivery problem.
6.2 billion dollars on HCP digital marketing in 2025. 97 percent ignored. The fix is not more channels.
Pharma marketing has been measured wrong for a decade. Activity has been the proxy for value because output is hard to measure. The result is a system that produces 6.2 billion dollars worth of HCP marketing per year, 97 percent of which gets ignored.
Inside the industry, 82 percent of pharma executives believe their digital outreach is working. Only 28 percent of HCPs agree. That 54 point confidence gap exists because the people defining what working means are the same people funding the budget. Activity dashboards show high send volumes. Engagement reports show clicks. Almost nobody asks whether any of it changed prescribing.
The companies that move first will not be the ones with bigger budgets or smarter agencies. They will be the ones who shift from volume to relevance. One email that knows what the HCP prescribed last month outperforms 50 generic blasts. This collection is about what actually moves HCP behavior, what does not, and where the industry is heading.
Key Insights
What the numbers are showing.
Pharma spent 6.2 billion dollars on HCP digital marketing in 2025. 97 percent of it got ignored.
Open rates on traditional pharma email sit around 5 percent. Response rates around 1 percent.
82 percent of pharma execs think digital outreach is working. Only 28 percent of HCPs agree.
Text messages to HCPs reach up to 98 percent open rates. WhatsApp medical content gets 50 percent engagement vs 6 percent for email.
Every ignored email trains the HCP to filter you harder. The cost compounds.
Questions
What people ask about pharma marketing.
Want to talk about how this applies to your organization?
30 minute call. No deck. We will figure out if I can help.